Clinical Trial Update: The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ursodeoxycholic acid for treating gallstones in patients with hemolytic disorders was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholelithiasis
• Hemolytic Anemia

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Hemolytic Disorders, Gallstones | Phase 4 | Status: TERMINATED